Premier Alternatives

Portal Biotechnologies

Watertown, MA · Founded 2023 · Privately Held (backing)

Developer of a cell engineering platform designed to enable novel cell analytics and next-generation cell therapies. Portal Biotechnologies is based in Watertown, MA and was founded in 2023. Its last reported valuation was $34.8 million in Dec 2024. It has raised $12 million across 2 recorded rounds; the latest was a $9 million early-stage round in May 2026.

Last reported valuation
$34.8M
Oct 2026
Priced at
—
Total raised
$12.0M
Last round
Early Stage VC
May 2026

Portal Biotechnologies key facts

as of Oct 2026
  • Developer of a cell engineering platform designed to enable novel cell analytics and next-generation cell therapies.
  • Portal Biotechnologies is valued at approximately $34.8M as of Oct 2026 (last reported valuation).
  • It has raised $12.0M across 2 recorded rounds; the latest was Early Stage VC ($9.0M) in May 2026.
  • Notable investors include Pear (California), Page One Ventures, Scale Good Fund, IA Ventures, 10X Capital — 8 tracked in total.
  • Portal Biotechnologies has filed 3 Form Ds with the SEC since 2024, most recently May 2026 ($11.7M sold to 43 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$34.8M

Portal Biotechnologies's last reported valuation, Dec 2024. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Portal Biotechnologies with a free account
  • ·Watch Portal Biotechnologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Portal Biotechnologies funding rounds

2 rounds
May 2026Early Stage VC$9.0MSEC filing▮
Dec 2024Early Stage VC$11.7MSEC filing▮
Full funding history →

Portal Biotechnologies valuation

Portal Biotechnologies's last reported valuation was $34.8 million in Dec 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has Portal Biotechnologies raised?

Portal Biotechnologies has raised $12 million across 2 recorded rounds since 2024. The largest was a $9 million early-stage round in May 2026.

Portal Biotechnologies has filed 3 Form Ds with the SEC since 2024, most recently in May 2026 ($11.7 million sold to 43 investors).

Portal Biotechnologies investors

8 investors are on record for Portal Biotechnologies, including Pear (California), Page One Ventures, Scale Good Fund and IA Ventures. The early-stage round in May 2026 drew 12 investors.

About Portal Biotechnologies

Developer of a cell engineering platform designed to enable novel cell analytics and next-generation cell therapies. The company is implementing a simplified approach to intracellular delivery, focused on accelerating advances stimulated by the new generation of RNA, gene editing, and molecular design technologies, enabling the healthcare sector with research and clinical-scale technologies.

Sector
Healthcare
HQ
Watertown, MA, United States
Founded
2023
Employees
15
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.